Nsengimana

Vitamin D–VDR signaling inhibits Wnt/β-Catenin–mediated melanoma progression and promotes antitumor immunity

*Cancer Research* 2019; 79(23):5986-5998

MX 2 is a novel regulator of cell cycle in melanoma cells

*Pigment Cell & Melanoma Research* 2019; 33(3):446-457

A higher percentage of stroma within primary melanomas is associated with a protective effect on melanoma-specific survival

*Journal of the American Academy of Dermatology* 2019; 81(4):AB6

Transcriptomic analysis reveals prognostic molecular signatures of stage I melanoma

*Clinical Cancer Research* 2019; 25(24):7424-7435

High-resolution copy number patterns from clinically relevant FFPE material

*Scientific Reports* 2019; 9:8098

ctDNA as a noninvasive monitoring tool in metastatic melanoma

*Journal of Clinical Oncology* 2019; 37(Suppl 15):9548

Genetic and environmental determinants of immune response to cutaneous melanoma

*Cancer Research* 2019; 79(10):2684-2696

Application of Circulating cell-free tumor DNA profiles for therapeutic monitoring and outcome prediction in genetically heterogeneous metastatic melanoma

*Journal of Clinical Oncology* 2019; 3:1-10

MYCexpression and smoking as drivers of failure of immune response to melanoma

*Tumor Biology* 2018; 78(Suppl 13):Abstract 5204

Primary melanoma expression of the vitamin D receptor (VDR) is protective for melanoma survival and is associated with increased tumor immune response, decreased Wnt/B-catenin signaling and tumor proliferation

*Tumor Biology* 2018; 78(Suppl 13):Abstract 5205